Skip to main content
Livermore
Livermore
ZHEN

Altium Capital Management LP

SEC CIK
0001746382
Latest filing
Aug 12, 2026

The latest 13F from Altium Capital Management LP covers Q2 2026 (filed Aug 12, 2026): 19 long positions worth $47.5M. The top 10 holdings make up 69.3% of the portfolio, and the largest is Royce Micro-Cap Trust, Inc. (RMT) at 8.6%. Livermore has 24 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
0
Added
6
Est. +$2.14M
Reduced
1
Est. −$537.1K
Sold out
0

Top 5 holdings

Share of this quarter's portfolio value

  1. RMTRoyce Micro-Cap Trust, Inc.
    8.6%$4.07MHistory
  2. ASAASA Gold & Precious Metals Ltd
    7.7%$3.66MHistory
  3. RVTRoyce Small-Cap Trust, Inc.
    7.5%$3.56MHistory
  4. NBXGNeuberger Next Generation Connectivity Fund Inc.
    7.1%$3.38MHistory
  5. PDXPIMCO Dynamic Income Strategy Fund
    6.9%$3.28MHistory

Share of portfolio

Top 5 holdings and the other 14 positions, by share of portfolio value

  1. RMT8.6%
  2. ASA7.7%
  3. RVT7.5%
  4. NBXG7.1%
  5. PDX6.9%
  6. Other 14 positions62.2%

Biggest buys

New and added positions, by estimated amount bought

  1. ASAASA Gold & Precious Metals Ltd
    +$945.6KAddedHistory
  2. RMTRoyce Micro-Cap Trust, Inc.
    +$512.4KAddedHistory
  3. HFROHighland Opportunities & Income Fund
    +$285.1KAddedHistory
  4. TYTRI-CONTINENTAL Corp
    +$259.5KAddedHistory
  5. GFNew Germany Fund Inc
    +$93.7KAddedHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. RMTRoyce Micro-Cap Trust, Inc.
    +2.03 pp6.5% → 8.6%History
  2. HFROHighland Opportunities & Income Fund
    +1.00 pp3.8% → 4.8%History
  3. TYTRI-CONTINENTAL Corp
    +0.34 pp5.9% → 6.3%History
  4. GFNew Germany Fund Inc
    +0.19 pp0.6% → 0.8%History
  5. NDRAENDRA Life Sciences Inc.
    +0.09 pp0.6% → 0.7%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. AFBAlliancebernstein National Municipal Income Fund
    −$537.1KReducedHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. AFBAlliancebernstein National Municipal Income Fund
    −1.44 pp5.7% → 4.2%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$47.5M
+$5.45M (+13.0%) vs. prior quarter
Positions
19
0 vs. prior quarter
Top 10 concentration
69.3%
Top 10 as share of value
Turnover
1.2%
Q2 2026, one quarter
Average holding period
2.9 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $431.1M (Q2 2021)

Q1 2021: $360.3MQ2 2021: $431.1MQ3 2021: $374.8MQ4 2021: $356.0MQ1 2022: $287.0MQ2 2022: $236.5MQ3 2022: $265.7MQ4 2022: $195.5MQ1 2023: $167.4MQ2 2023: $127.9MQ3 2023: $172.8MQ4 2023: $145.1MQ1 2024: $223.9MQ2 2024: $242.1MQ3 2024: $335.7MQ4 2024: $321.1MQ1 2025: $34.4MQ3 2025: $628.3KQ4 2025: $25.3MQ1 2026: $42.0MQ2 2026: $47.5M
Q1 2021Q2 2026
13F filings of Altium Capital Management LP by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 12, 202619$47.5MRMTASARVTvs. Q1 2026SEC
Q1 2026May 1, 202619$42.0MPDXASARVTvs. Q4 2025SEC
Q4 2025Feb 6, 202618$25.3MASARVTPDXvs. Q3 2025SEC
Q3 2025Nov 4, 20251$628.3KCNSYvs. Q2 2025SEC
Q2 2025Aug 7, 20250$0–vs. Q1 2025SEC
Q1 2025May 13, 2025Amended22$34.4MZVRAEOLSXTNTvs. Q4 2024SEC
Q4 2024Feb 13, 202561$321.1MADMAVERASRPTvs. Q3 2024SEC
Q3 2024Nov 14, 202475$335.7MVERAADMASRPTvs. Q2 2024SEC
Q2 2024Aug 15, 202464$242.1MVERAADMAXENEvs. Q1 2024SEC
Q1 2024May 15, 202468$223.9MVERAXENEAXSMvs. Q4 2023SEC
Q4 2023Feb 14, 202463$145.1MXENEALIMAXSMvs. Q3 2023SEC
Q3 2023Nov 14, 202366$172.8MCBAYIMGNATXSvs. Q2 2023SEC
Q2 2023Aug 14, 202364$127.9MKDNYATXSIMGNvs. Q1 2023SEC
Q1 2023May 15, 202389$167.4MATXSADMABellus Health Inc Newvs. Q4 2022SEC
Q4 2022Feb 14, 202391$195.5MATXSADMAKDNYvs. Q3 2022SEC
Q3 2022Nov 14, 2022130$265.7MBellus Health Inc NewKDNYChemoCentryx, Inc.vs. Q2 2022SEC
Q2 2022Aug 15, 2022120$236.5MKDNYBellus Health Inc NewADMAvs. Q1 2022SEC
Q1 2022May 16, 2022117$287.0MESPRBellus Health Inc NewPTGXvs. Q4 2021SEC
Q4 2021Feb 14, 2022131$356.0MESPRPTGXBellus Health Inc Newvs. Q3 2021SEC
Q3 2021Nov 17, 2021Amended121$374.8M1847 Goedeker IncBellus Health Inc NewCLDXvs. Q2 2021SEC
Q2 2021Aug 13, 2021135$431.1M1847 Goedeker IncXTNTPTGXvs. Q1 2021SEC
Q1 2021May 6, 2021124$360.3MCRISVRCABIOR–SEC

13D and 13G filings

Companies where Altium Capital Management LP reports owning 5% or more on Schedule 13D or 13G, and its latest filings.

Current stakes of 5% or more

2 companies, largest stake first.

Companies where Altium Capital Management LP owns 5% or more
CompanyLatest formStakeChangeFirst filedLatest filingFiling
GNLNGreenlane Holdings, Inc.13G9.99%2.52M sharesNewFeb 28, 20251 filingFeb 28, 2025SEC
FMTOFFemto Technologies Inc.13G9.58%479.6K sharesNewMar 6, 20251 filingMar 6, 2025SEC

Latest filings

123 filings on file made by Altium Capital Management LP or listing it as a reporting person; the latest 20 are shown.

Schedule 13D and 13G filings by Altium Capital Management LP
CompanyFiled (ET)FormStakeChangeEvent dateFiling
XPONExpion Energy, Inc.Nov 4, 202512:37 PM ET13G/A0.00%0 shares–Below 5%Sep 30, 2025SEC
SKYAWSkyAI, Inc.Aug 14, 202511:01 AM ET13G/A3.48%35.7K shares−6.51 ppfrom 9.99%Below 5%Jun 30, 2025SEC
CETXCemtrex IncAug 14, 202510:35 AM ET13G/A0.00%0 shares–Below 5%Jun 30, 2025SEC
SBFMSunshine Biopharma Inc.Aug 14, 202510:35 AM ET13G/A0.00%0 shares–Below 5%Jun 30, 2025SEC
FMTOFFemto Technologies Inc.Aug 14, 202510:35 AM ET13G/A0.22%6.58K shares–Below 5%Jun 30, 2025SEC
GNLNGreenlane Holdings, Inc.Aug 14, 202510:34 AM ET13G/A0.12%21.0K shares–Below 5%Jun 30, 2025SEC
LGMKLogicMark, Inc.Aug 14, 202510:33 AM ET13G/A3.11%1.88M shares–Below 5%Jun 30, 2025SEC
SRXHSRX Global Inc.May 15, 202510:56 AM ET13G/A0.27%39.0K shares−5.83 ppfrom 6.10%Below 5%Mar 31, 2025SEC
KUSTKustom Entertainment, Inc.May 15, 202510:54 AM ET13G/A4.99%40.0M shares−5.00 ppfrom 9.99%Below 5%Mar 31, 2025SEC
FMTOFFemto Technologies Inc.Mar 6, 20259:02 PM ET13G9.58%479.6K sharesNewFeb 28, 2025SEC
GNLNGreenlane Holdings, Inc.Feb 28, 20253:35 PM ET13G9.99%2.52M sharesNewFeb 26, 2025SEC
KUSTKustom Entertainment, Inc.Feb 24, 202510:23 AM ET13G9.99%12.8M sharesNewFeb 13, 2025SEC
ELABPMGC Holdings Inc.Feb 14, 202511:14 AM ET13G/A3.90%193.9K shares–Below 5%Dec 31, 2024SEC
SRXHSRX Global Inc.Feb 14, 202511:10 AM ET13G/A6.10%463.5K shares–Dec 31, 2024SEC
SKYASkyAI, Inc.Feb 5, 20256:24 PM ET13G9.99%549.3K sharesNewJan 28, 2025SEC
EMPDEmpery Digital Inc.Nov 14, 202413G/AOld format–––SEC
SKYESkye Bioscience, Inc.Nov 14, 202413G/AOld format–––SEC
EVOKEvoke Pharma IncNov 14, 202413G/AOld format–––SEC
SRXHSRX Global Inc.Nov 14, 202413G/AOld format–––SEC
ELABPMGC Holdings Inc.Sep 26, 202413GOld format–New–SEC